ethacrynic sodium

Product NDC: 68682-012
11-digit product format: 686820012
Labeler code: 68682
Product ID: 68682-012_4180744c-a9ab-48e6-9b25-ea37a04add74
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ethacrynic sodium
Dosage form: POWDER, FOR SOLUTION
Route: INTRAVENOUS
Labeler: Oceanside Pharmaceuticals
Application: NDA016093
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 1967-01-10
Marketing end: 0000-00-00
Substance: ETHACRYNATE SODIUM
Active strength: 50 mg/50mL
Pharmacologic classes: Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	68682-012		D	Discontinued by firm	2026-08-10
excluded product	product	68682-012		D	Discontinued by firm	2026-08-10
excluded package	package	68682-012	68682-012-27	D	Discontinued by firm	2026-08-10
excluded package	package	68682-012	68682-012-50	D	Discontinued by firm	2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 50 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68682-012-27	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68682-012-50	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68682-012-27	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68682-012-50	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68682-012-27	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68682-012-50	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68682-012-27	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68682-012-50	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68682-012-27	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68682-012-50	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68682-012-27	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68682-012-50	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68682-012-27	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68682-012-50	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68682-012-27	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68682-012-50	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68682-012-27	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68682-012-50	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68682-012-27	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68682-012-50	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68682-012-27	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68682-012-50	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	68682-012-27	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	68682-012-27	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	68682-012-27	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N016093-001	EDECRIN	ETHACRYNATE SODIUM	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N016093-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N016093-001	EDECRIN	EQ 50MG BASE/VIAL	INJECTABLE / INJECTION	AP	RLD, RS, Approved before 1982	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N016093-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N016093-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N016093-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N016093-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N016093-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N016093-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N016093-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N016093-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N016093-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N016093-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N016093-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N016093-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N016093-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N016093-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N016093-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N016093-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N016093-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N016093-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N016093-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N016093-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N016093-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N016093-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N016093-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N016093-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N016093-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N016093-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N016093-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N016093-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N016093-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N016093-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N016093-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N016093-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N016093-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N016093-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N016093-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N016093-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N016093-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N016093-001	AP	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N016093-001	AP	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N016093-001	AP	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
93aead9c-5c26-5d19-73e9-d6c55a939061	Product name	9	20210525
01098bd8-4859-4cc2-9426-3489bf88d451	Product name	4	20201216

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68682-012-27	2023-08-31	C162847	48780-1	d6a99b39-e4e3-a426-e053-dadaa90af4c2	TABLETS ETHACRYNIC ACID and INTRAVENOUS ETHACRYNATE SODIUM
68682-012-27	2022-01-28	C162847	48780-1	d6a99b39-e4e3-a426-e053-dadaa90af4c2	TABLETS ETHACRYNIC ACID and INTRAVENOUS ETHACRYNATE SODIUM

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68682-012-27	ethacrynic sodium	1 in 1 CARTON	POWDER, FOR SOLUTION	1		14
68682-012-27	ethacrynic sodium	50 mL in 1 VIAL	POWDER, FOR SOLUTION	50		14

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68682-012-27	EA - Each	68682-012	238c069d-6844-4b4b-9144-baf7a37495ec	1	2016-02-04
68682-012-50	EA - Each	68682-012	08f74d7f-097e-4c27-83cf-3864b23973f2	1	2018-03-08

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ETHACRYNATE SODIUM	ACTIVE INGREDIENT	K41MYV7MPM	ETHACRYNIC SODIUM POWDER, FOR SOLUTION [OCEANSIDE PHARMACEUTICALS]	1
ETHACRYNIC ACID	ACTIVE MOIETY	M5DP350VZV	ETHACRYNIC SODIUM POWDER, FOR SOLUTION [OCEANSIDE PHARMACEUTICALS]	1
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	ETHACRYNIC SODIUM POWDER, FOR SOLUTION [OCEANSIDE PHARMACEUTICALS]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68682-012	ETHACRYNIC SODIUM POWDER, FOR SOLUTION ETHACRYNIC ACID TABLET [OCEANSIDE PHARMACEUTICALS]	14	Legacy NDC, 2 package rows	20240802_f127598f-e6b3-4c35-800f-76e4217595ae.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ethacrynic acid	ETHACRYNIC ACID	Oceanside Pharmaceuticals	f127598f-e6b3-4c35-800f-76e4217595ae	2023-08-31	Warnings, Adverse reactions	Exact identifier ndc (product): 68682-012

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
K41MYV7MPM	ETHACRYNATE SODIUM	6500-81-8	ETHACRYNATE SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
617325	ethacrynate sodium 50 MG Injection	PSN	f127598f-e6b3-4c35-800f-76e4217595ae	14
1251903	ethacrynic acid 25 MG Oral Tablet	PSN	f127598f-e6b3-4c35-800f-76e4217595ae	14
617325	ethacrynate sodium 50 MG Injection	SCD	f127598f-e6b3-4c35-800f-76e4217595ae	14
1251903	ethacrynic acid 25 MG Oral Tablet	SCD	f127598f-e6b3-4c35-800f-76e4217595ae	14
617325	ethacrynate sodium 50 MG (equivalent to ethacrynic acid 50 MG) Injection	SY	f127598f-e6b3-4c35-800f-76e4217595ae	14

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68682-012-27	68682001227	1 VIAL in 1 CARTON (68682-012-27) > 50 mL in 1 VIAL	1 vial	1967-01-10	0000-00-00	No	No	Current
68682-012-50	68682001250	1 VIAL in 1 CARTON (68682-012-50) > 50 mL in 1 VIAL	1 vial	1967-01-10	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
TABLETS ETHACRYNIC ACID and INTRAVENOUS ETHACRYNATE SODIUM	Oceanside Pharmaceuticals \| Patheon Manufacturing Services LLC \| Bausch Health Companies Inc.	2023-08-31	HUMAN PRESCRIPTION DRUG LABEL	14
TABLETS ETHACRYNIC ACID and INTRAVENOUS ETHACRYNATE SODIUM	Oceanside Pharmaceuticals \| Patheon Manufacturing Services LLC \| Carton Service, Incorporated	2021-01-01	HUMAN PRESCRIPTION DRUG LABEL	4